The COVID-19 vaccine developed by Pfizer Inc. and BioNTech SE has proven less effective against the new Omicron variant of the virus in an early trial conducted in South Africa.
The immune protection against the mutated strain has reduced by around 40% in double-vaccinated individuals when compared to the protection against the original variant. The defence is still “robust, but not complete,” researchers at the Africa Health Research Institute found.
“A good booster probably would decrease your chance of infection, especially severe infection leading to more severe disease,” the nation’s expert virologist, Professor Alex Sigal, said, adding, “People who haven’t had a booster should get one, and people who have been previously infected should be vaccinated.”
Algerian firmness on questions of memory Algerian President Abdelmadjid Tebboune reaffirmed Algeria's determination concerning the…
The United Nations Department of Peace Operations has announced that Major Ahlem Douzi, who serves as…
British Minister of State for the Middle East, North Africa, South Asia, Commonwealth and United…
Security forces in the National Guard district of Thala, Kasserine region, apprehended an individual from…
Budding geniuses have an appointment with the 2023 Nobel Prize in Chemistry, Mongi Bawendi. The…
The Free Destourian Party revealed, in a press release, issued yesterday Monday, that it “will lodge…
This website uses cookies.